Establishment of an induced pluripotent stem cell line (NCKDi003-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p. T277P (c. 829A > C) in the CLCN5 gene

被引:2
|
作者
Hu, Lidan [1 ]
Wang, Gang [3 ]
Wu, Hangdi [4 ]
Fu, Haidong [1 ]
Wang, Yan [4 ]
Yu, Fan [4 ]
Liu, Zhihong [2 ,3 ,4 ]
Mao, Jianhua [1 ]
机构
[1] Zhejiang Univ, Natl Clin Res Ctr Child Hlth, Sch Med, Childrens Hosp, Hangzhou 310052, Peoples R China
[2] Zhejiang Univ, Med Ctr, Zhejiang Lab Syst & Precis Med, 1369 West Wenyi Rd, Hangzhou, Peoples R China
[3] Nanjing Univ, Jinling Hosp, Sch Med, Natl Clin Res Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China
[4] Zhejiang Univ, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.scr.2021.102538
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Dent disease (DD) is a rare X-linked proximal tubulopathy associated with low molecular weight proteinuria (LMWP), hypercalciuria, nephrolithiasis and phosphoruria, which may progress to chronic kidney disease (CKD). About 60% of cases are caused by the mutation in CLCN5 gene. Recently, we identified a mutation in the sequence of homodimer of CLCN5 gene in a patient with DD. The Peripheral Blood Mononuclear Cells (PBMCs) of the patient were obtained and a line of induced pluripotent stem cells (iPSCs) was successfully generated. The iPSC line will be useful for further study of the pathogenesis and drug screening for DD.
引用
收藏
页数:4
相关论文
共 36 条
  • [1] Establishment of an induced pluripotent stem cell line (WMUi016-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p.R718*(c.2152C > T) in the CLCN5 ge ne
    Chen, Huihui
    Ding, Yinjuan
    Zhou, Weizhong
    Li, Jiajia
    Qian, Weite
    Zhang, Zhe
    Li, Chao
    Tong, Hongfei
    Rong, Xing
    Chu, Maoping
    Chen, Congde
    Wang, Dexuan
    Guo, Xiaoling
    STEM CELL RESEARCH, 2021, 51
  • [2] Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T>A) mutation in JAGGED-1
    Brooks, Brianna M.
    Pradhan, Manisha
    Cheng, Yu-Shan
    Gorshkov, Kirill
    Farkhondeh, Atena
    Chen, Catherine Z.
    Beers, Jeanette
    Liu, Chengyu
    Baumgaertel, Karsten
    Rodems, Steven
    Zheng, Wei
    STEM CELL RESEARCH, 2021, 54
  • [3] Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X -linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene
    Sun, Lei
    Zhang, Jing
    Kuang, Xin-yu
    Kang, Yu-lin
    Wu, Ying
    Huang, Wen-yan
    STEM CELL RESEARCH, 2020, 45
  • [4] Generation of an induced pluripotent stem cell line (TRNDi042-A) from a Mucopolysaccharidosis type IIIB patient with homozygous p. R626X (c. 1876C > T) mutation in the NAGLU gene
    Rodriguez-Lopez, Alexander
    Huang, Xiuli
    Chen, Catherine
    Zou, Jizhong
    Zheng, Wei
    Chen, Guibin
    STEM CELL RESEARCH, 2024, 81
  • [5] An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene
    Yang, Shu
    Cheng, Yu-Shan
    Li, Rong
    Pradhan, Manisha
    Hong, Junjie
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Might, Matt
    Rodems, Steven
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 39
  • [6] Establishment of an induced pluripotent stem cell line from a Noonan syndrome patient with the heterozygote mutation p.S257L (c.770C > T) in RAF1 gene
    Guo, Xiaoling
    Qian, Rengcheng
    Yang, Liang
    Chen, Huihui
    Ding, Yinjuan
    Shan, Xiaoou
    Chen, Congde
    Ni, Wenfei
    Lin, Jian
    Chu, Maoping
    STEM CELL RESEARCH, 2021, 53
  • [7] Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1
    Brooks, Brianna M.
    Yeh, Charles D.
    Beers, Jeanette
    Liu, Chengyu
    Cheng, Yu-Shan
    Gorshkov, Kirill
    Zou, Jizhong
    Zheng, Wei
    Chen, Catherine Z.
    STEM CELL RESEARCH, 2021, 53
  • [8] An induced pluripotent stem cell line (TRNDi001-D) from a Niemann-Pick disease type C1 (NPC1) patient carrying a homozygous p. I1061T (c. 3182 T>C ) mutation in the NPC1 gene
    Li, Rong
    Pradhan, Manisha
    Xu, Miao
    Roeder, Amanda
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Porter, Forbes D.
    Zhen, Wei
    STEM CELL RESEARCH, 2020, 44
  • [9] Generation of an urine-derived induced pluripotent stem cell line WMUi017-A from a X-linked Renpenning syndrome (X-RSY) patient with the hemizygous PQBP1 gene mutation p.P609A (c.1825C>G)
    Guo, Xiaoling
    Zhang, Xufei
    Wang, Linlin
    He, Lingyun
    Ding, Yinjuan
    Chen, Huihui
    Wang, Dexuan
    Rong, Xing
    Shen, Xian
    Lin, Jian
    Chu, Maoping
    STEM CELL RESEARCH, 2021, 51
  • [10] Generation of an induced pluripotent stem cell (iPSC) line from a Parkinson 's disease patient with a pathogenic LRP10/c.688C > T(p. Arg230Trp) mutation
    Wang, Yan
    Wei, Chuanfei
    Liu, Yanming
    Lu, Xianjie
    Wang, Wei
    Song, Na
    Zhang, Wei
    Xu, Jun
    Zhang, Wei
    Han, Fabin
    STEM CELL RESEARCH, 2024, 77